Capital Performance Advisors LLP Nautilus Biotechnology, Inc. Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 7 shares of NAUT stock, worth $18. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7Holding current value
$18% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NAUT
# of Institutions
83Shares Held
63.9MCall Options Held
2.9KPut Options Held
500-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$42.5 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$32.9 Million0.85% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$18.7 Million0.45% of portfolio
-
Madrona Venture Group, LLC6.02MShares$15.7 Million15.03% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$9.99 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $325M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...